Literature DB >> 31673128

ADCK3/COQ8A: the choice target of the UbiB protein kinase-like family.

Christopher R M Asquith, Nathan H Murray, David J Pagliarini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31673128      PMCID: PMC7062282          DOI: 10.1038/d41573-019-00158-w

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  2-Propylphenol Allosterically Modulates COQ8A to Enhance ATPase Activity.

Authors:  Nathan H Murray; Adam Lewis; Juan P Rincon Pabon; Michael L Gross; Katherine Henzler-Wildman; David J Pagliarini
Journal:  ACS Chem Biol       Date:  2022-07-29       Impact factor: 4.634

2.  Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype.

Authors:  Christopher R M Asquith; Louisa Temme; Michael P East; Tuomo Laitinen; Julie Pickett; Frank E Kwarcinski; Parvathi Sinha; Carrow I Wells; Gary L Johnson; Reena Zutshi; David H Drewry
Journal:  ChemMedChem       Date:  2022-05-09       Impact factor: 3.540

3.  Regulatory spine RS3 residue of protein kinases: a lipophilic bystander or a decisive element in the small-molecule kinase inhibitor binding?

Authors:  Ekaterina Shevchenko; Tatu Pantsar
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

4.  Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform.

Authors:  Andrew A Bieberich; Tuomo Laitinen; Kaitlyn Maffuid; Raymond O Fatig; Chad D Torrice; David C Morris; Daniel J Crona; Christopher R M Asquith
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

5.  UbiB proteins regulate cellular CoQ distribution in Saccharomyces cerevisiae.

Authors:  Zachary A Kemmerer; Kyle P Robinson; Jonathan M Schmitz; Mateusz Manicki; Brett R Paulson; Adam Jochem; Paul D Hutchins; Joshua J Coon; David J Pagliarini
Journal:  Nat Commun       Date:  2021-08-06       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.